Remove center-orphan-drug-research resources
article thumbnail

Why Is Nobody Using Your Guidelines? – Insights On Designing Useful Guidelines For Infectious Diseases

IDStewardship

Additionally, the Centers for Medicaid & Medicare Service (CMS) Center for Clinical Standards and Quality/Quality, Safety & Oversight Group released updates to interpretive guidance for hospital requirements, making their antimicrobial stewardship regulations live now.

Hospitals 130
article thumbnail

Clinical success begins early for small molecule drugs

European Pharmaceutical Review

1 Within these programmes, the ability to identify and solve challenges in the early stages with agility and flexibility is critical to successful early clinical trials that will help advance drugs from late stage through product launch. Addressing bioavailability challenges for small molecule drugs.

article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. Cablivi stops platelets from clumping together, which prevents small clots, and can be used along with other drugs that suppress the immune system.